Follow
Naomi Visanji
Naomi Visanji
Edmond J. Safra program in Parkinson's disease and the Morton and Gloria Shulman Movement disorders
Verified email at uhnresearch.ca - Homepage
Title
Cited by
Cited by
Year
Gastrointestinal dysfunction in Parkinson's disease
A Fasano, NP Visanji, LWC Liu, AE Lang, RF Pfeiffer
The Lancet Neurology 14 (6), 625-639, 2015
5572015
The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration
MJ O'neill, TK Murray, V Lakics, NP Visanji, S Duty
Current Drug Targets-CNS & Neurological Disorders 1 (4), 399-411, 2002
2692002
The prion hypothesis in Parkinson's disease: Braak to the future
NP Visanji, PL Brooks, LN Hazrati, AE Lang
Acta neuropathologica communications 1 (1), 1-12, 2013
2672013
Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
P Huot, TH Johnston, T Darr, LN Hazrati, NP Visanji, D Pires, JM Brotchie, ...
Movement disorders 25 (10), 1399-1408, 2010
1412010
Dietary resveratrol administration increases MnSOD expression and activity in mouse brain
EL Robb, L Winkelmolen, N Visanji, J Brotchie, JA Stuart
Biochemical and biophysical research communications 372 (1), 254-259, 2008
1322008
α-Synuclein-based animal models of Parkinson's disease: challenges and opportunities in a new era
NP Visanji, JM Brotchie, LV Kalia, JB Koprich, A Tandon, JC Watts, ...
Trends in neurosciences 39 (11), 750-762, 2016
1232016
Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease
NP Visanji, C Marras, DS Kern, A Al Dakheel, A Gao, LWC Liu, AE Lang, ...
Neurology 84 (6), 609-616, 2015
1232015
α-Synuclein strains target distinct brain regions and cell types
A Lau, RWL So, HHC Lau, JC Sang, A Ruiz-Riquelme, SC Fleck, E Stuart, ...
Nature neuroscience 23 (1), 21-31, 2020
1182020
α-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity*♦
RHC Chen, S Wislet-Gendebien, F Samuel, NP Visanji, G Zhang, ...
Journal of Biological Chemistry 288 (11), 7438-7449, 2013
1082013
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice
DGM Jugloff, K Vandamme, R Logan, NP Visanji, JM Brotchie, ...
Human molecular genetics 17 (10), 1386-1396, 2008
1042008
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
NP Visanji, SH Fox, T Johnston, G Reyes, MJ Millan, JM Brotchie
Neurobiology of disease 35 (2), 184-192, 2009
1012009
Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
NP Visanji, J Gomez‐Ramirez, TH Johnston, D Pires, V Voon, JM Brotchie, ...
Movement disorders: official journal of the Movement Disorder Society 21 (11 …, 2006
922006
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a …
CW Ip, LC Klaus, AA Karikari, NP Visanji, JM Brotchie, AE Lang, ...
Acta neuropathologica communications 5 (1), 1-12, 2017
872017
Alimentary, my dear Watson? The challenges of enteric α‐synuclein as a Parkinson's disease biomarker
NP Visanji, C Marras, LN Hazrati, LWC Liu, AE Lang
Movement Disorders 29 (4), 444-450, 2014
872014
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons …
NP Visanji, A Orsi, TH Johnston, PA Howson, K Dixon, N Callizot, ...
The FASEB Journal 22 (7), 2488-2497, 2008
862008
Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranes
NP Visanji, S Wislet-Gendebien, LW Oschipok, G Zhang, I Aubert, ...
Journal of Biological Chemistry 286 (41), 35863-35873, 2011
722011
Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease
KS Kim, PC Marcogliese, J Yang, SM Callaghan, V Resende, ...
Proceedings of the National Academy of Sciences 115 (22), E5164-E5173, 2018
672018
Histamine H3 receptor agonists reduce L‐dopa–induced chorea, but not dystonia, in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
J Gomez‐Ramirez, TH Johnston, NP Visanji, SH Fox, JM Brotchie
Movement disorders 21 (6), 839-846, 2006
622006
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson’s disease
SH Fox, N Visanji, G Reyes, P Huot, J Gomez-Ramirez, T Johnston, ...
Canadian journal of neurological sciences 37 (1), 86-95, 2010
602010
Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy
NP Visanji, JF Collingwood, ME Finnegan, A Tandon, E House, ...
Journal of Parkinson's disease 3 (4), 523-537, 2013
552013
The system can't perform the operation now. Try again later.
Articles 1–20